Skip to content
Open access

Effectiveness of orthokeratology plus vision therapy for controlling myopia progression in children.

2026 · American journal of translational research · Vol 18 8, pp. 6928-6937 · 0 citations
Medicine

Abstract

Objective

Addressing myopia in children, this study analyzed the effectiveness of orthokeratology (Ortho-K) plus vision therapy (VT) for controlling myopia progression.

Methods

The study population was composed of 155 myopia-affected children (August 2022-August 2025), who were assigned to the ortho-K group (n=75) wearing Ortho-K lenses and the Ortho-K+VT group (n=80) that was additionally given VT intervention. Inter-group comparative assessments were then conducted from the perspectives of clinical effectiveness, visual acuity (VA) measures (best-corrected VA, uncorrected VA), refractive structural parameters (axial length, spherical equivalent), corneal parameters (central corneal thickness, mean keratometry), accommodation parameters (accommodation amplitude, accommodative facility, accommodative response), accommodation-convergence synergy parameters (positive/negative relative accommodation, accommodative convergence/accommodation ratio), complications (corneal epithelial punctate staining, conjunctival congestion, dry eye symptoms, papillary conjunctivitis), and vision-related quality of life (25-Item National Eye Institute Visual Function Questionnaire).

Results

The total effective rate was significantly higher in the Ortho-K+VT group than in the Ortho-K group. After the intervention, all VA measures, refractive structure parameters, corneal parameters, accommodation parameters, accommodation-convergence synergy parameters, and vision-related quality of life were significantly better in patients receiving Ortho-K+VT. The total complication rate was significantly lower in the Ortho-K+VT group than in the Ortho-K group.

Conclusion

Ortho-K combined with VT was effective in controlling myopia progression in children.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.